FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1792483306> ?p ?o ?g. }

• W1792483306 endingPage "9270" @default.
• W1792483306 startingPage "9257" @default.
• W1792483306 abstract "// Daquan Huang 1, 2 * , Shuwei Qiu 1 * , Ruiguang Ge 3 , Lei He 1 , Mei Li 1 , Yi Li 1 , Ying Peng 1, 2 1 Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China 2 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China 3 Key Laboratory of Gene Engineering of the Ministry of Education and State Key Laboratory of Biocontrol, College of Life Sciences, Sun Yat-Sen University, Guangzhou, China * These authors have contributed equally to this work Correspondence to: Ying Peng, e-mail: docpengy123@163.com Keywords: glioblastoma multiforme, miR-340, ROCK1, biomarker Received: January 07, 2015      Accepted: February 07, 2015      Published: March 16, 2015 ABSTRACT Deregulation of microRNAs (miRs) contributes to tumorigenesis. Down-regulation of miR-340 is observed in multiple types of cancers. However, the biological function of miR-340 in glioblastoma multiforme (GBM) remains largely unknown. In the present study, we demonstrated that expression of miR-340 was downregulated in both glioma cell lines and tissues. Survival of GBM patients with high levels of miR-340 was significantly extended in comparison to patients expressing low miR-340 levels. Biological functional experiments showed that the restoration of miR-340 dramatically inhibited glioma cell proliferation, induced cell-cycle arrest and apoptosis, suppressed cell motility and promoted autophagy and terminal differentiation. Mechanistic studies disclosed that, miR-340 over-expression suppressed several oncogenes including p-AKT, EZH2, EGFR, BMI1 and XIAP. Furthermore, ROCK1 was validated as a direct functional target miR-340 and silencing of ROCK1 phenocopied the anti-tumor effect of mR-340. Our findings indicate an important role of miR-340 as a glioma killer, and suggest a potential prognosis biomarker and therapeutic target for GBM." @default.
• W1792483306 created "2016-06-24" @default.
• W1792483306 creator A5006991292 @default.
• W1792483306 creator A5009884211 @default.
• W1792483306 creator A5025003335 @default.
• W1792483306 creator A5039720944 @default.
• W1792483306 creator A5048514960 @default.
• W1792483306 creator A5054489408 @default.
• W1792483306 creator A5069689855 @default.
• W1792483306 date "2015-03-16" @default.
• W1792483306 modified "2023-10-16" @default.
• W1792483306 title "miR-340 suppresses glioblastoma multiforme" @default.
• W1792483306 cites W144423133 @default.
• W1792483306 cites W1555664180 @default.
• W1792483306 cites W1955837289 @default.
• W1792483306 cites W1963961997 @default.
• W1792483306 cites W1964378305 @default.
• W1792483306 cites W1967874387 @default.
• W1792483306 cites W1969564302 @default.
• W1792483306 cites W1975304818 @default.
• W1792483306 cites W1975377745 @default.
• W1792483306 cites W1982649435 @default.
• W1792483306 cites W1986072799 @default.
• W1792483306 cites W1993951400 @default.
• W1792483306 cites W2006417904 @default.
• W1792483306 cites W2022705243 @default.
• W1792483306 cites W2033210985 @default.
• W1792483306 cites W2036044314 @default.
• W1792483306 cites W2039597975 @default.
• W1792483306 cites W2049231966 @default.
• W1792483306 cites W2053035196 @default.
• W1792483306 cites W2064654243 @default.
• W1792483306 cites W2068208690 @default.
• W1792483306 cites W2077603983 @default.
• W1792483306 cites W2077847265 @default.
• W1792483306 cites W2080838269 @default.
• W1792483306 cites W2082678538 @default.
• W1792483306 cites W2086336177 @default.
• W1792483306 cites W2088392365 @default.
• W1792483306 cites W2094743676 @default.
• W1792483306 cites W2095593631 @default.
• W1792483306 cites W2106476697 @default.
• W1792483306 cites W2107480391 @default.
• W1792483306 cites W2107572410 @default.
• W1792483306 cites W2111635840 @default.
• W1792483306 cites W2112795018 @default.
• W1792483306 cites W2113088508 @default.
• W1792483306 cites W2115862526 @default.
• W1792483306 cites W2117812940 @default.
• W1792483306 cites W2122991820 @default.
• W1792483306 cites W2128064256 @default.
• W1792483306 cites W2128665281 @default.
• W1792483306 cites W2134807618 @default.
• W1792483306 cites W2135687976 @default.
• W1792483306 cites W2144841919 @default.
• W1792483306 cites W2145006562 @default.
• W1792483306 cites W2154406133 @default.
• W1792483306 cites W2159888101 @default.
• W1792483306 cites W2160609627 @default.
• W1792483306 cites W2164601967 @default.
• W1792483306 cites W2314575442 @default.
• W1792483306 doi "https://doi.org/10.18632/oncotarget.3288" @default.
• W1792483306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4496215" @default.
• W1792483306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25831237" @default.
• W1792483306 hasPublicationYear "2015" @default.
• W1792483306 type Work @default.
• W1792483306 sameAs 1792483306 @default.
• W1792483306 citedByCount "84" @default.
• W1792483306 countsByYear W17924833062015 @default.
• W1792483306 countsByYear W17924833062016 @default.
• W1792483306 countsByYear W17924833062017 @default.
• W1792483306 countsByYear W17924833062018 @default.
• W1792483306 countsByYear W17924833062019 @default.
• W1792483306 countsByYear W17924833062020 @default.
• W1792483306 countsByYear W17924833062021 @default.
• W1792483306 countsByYear W17924833062022 @default.
• W1792483306 countsByYear W17924833062023 @default.
• W1792483306 crossrefType "journal-article" @default.
• W1792483306 hasAuthorship W1792483306A5006991292 @default.
• W1792483306 hasAuthorship W1792483306A5009884211 @default.
• W1792483306 hasAuthorship W1792483306A5025003335 @default.
• W1792483306 hasAuthorship W1792483306A5039720944 @default.
• W1792483306 hasAuthorship W1792483306A5048514960 @default.
• W1792483306 hasAuthorship W1792483306A5054489408 @default.
• W1792483306 hasAuthorship W1792483306A5069689855 @default.
• W1792483306 hasBestOaLocation W17924833061 @default.
• W1792483306 hasConcept C104317684 @default.
• W1792483306 hasConcept C121608353 @default.
• W1792483306 hasConcept C126322002 @default.
• W1792483306 hasConcept C143998085 @default.
• W1792483306 hasConcept C145059251 @default.
• W1792483306 hasConcept C17744445 @default.
• W1792483306 hasConcept C199539241 @default.
• W1792483306 hasConcept C2776194525 @default.
• W1792483306 hasConcept C2778227246 @default.
• W1792483306 hasConcept C29537977 @default.
• W1792483306 hasConcept C502942594 @default.
• W1792483306 hasConcept C521751864 @default.

• next